Cure Rare Disease
non-profit biotechnology company
Based in MA
AI Overview
With $70K in lobbying spend across 6 quarterly filings, Cure Rare Disease is an active lobbying client. Their lobbying covers 1 issue area.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2022 | $70K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Cure Rare Disease disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues
Policies related to custom therapeutics for ultra-rare diseases.
Policies related to custom therapeutics for ultra-rare diseases; FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations.
Policies related to custom therapeutics for ultra-rare diseases; FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.8295, Senate).
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.